Grigg A - Search Results

1

Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.

Merli G, Spiro TE, Olsson CG, Abildgaard U, Davidson BL, Eldor A, Elias D, Grigg A, Musset D, Rodgers GM, Trowbridge AA, Yusen RD, Zawilska K; Enoxaparin Clinical Trial Group. Merli G, et al. Among authors: grigg a. Ann Intern Med. 2001 Feb 6;134(3):191-202. doi: 10.7326/0003-4819-134-3-200102060-00009. Ann Intern Med. 2001. PMID: 11177331 Clinical Trial.

2

Thrombotic thrombocytopenic purpura is associated with a high relapse rate after plasma exchange: a single-centre experience.

Frawley N, Ng AP, Nicholls K, Cohney S, Hogan C, Grigg A. Frawley N, et al. Among authors: grigg a. Intern Med J. 2009 Jan;39(1):19-24. doi: 10.1111/j.1445-5994.2008.01637.x. Epub 2008 Apr 14. Intern Med J. 2009. PMID: 18422566

3

Chemotherapy and granulocyte colony stimulating factor-mobilized blood cell infusion followed by interferon-alpha for relapsed malignancy after allogeneic bone marrow transplantation.

Grigg A, Kannan K, Schwarer AP, Spencer A, Szer J. Grigg A, et al. Intern Med J. 2001 Jan-Feb;31(1):15-22. doi: 10.1046/j.1445-5994.2001.00013.x. Intern Med J. 2001. PMID: 11478351 Clinical Trial.

4

Recommendations for the use of pegylated interferon-α in the treatment of classical myeloproliferative neoplasms.

Forsyth CJ, Chan WH, Grigg AP, Cook NC, Lane SW, Burbury KL, Perkins AC, Ross DM. Forsyth CJ, et al. Intern Med J. 2019 Aug;49(8):948-954. doi: 10.1111/imj.14154. Intern Med J. 2019. PMID: 30411442 Review.

5

Effect of hydroxyurea on sperm count, motility and morphology in adult men with sickle cell or myeloproliferative disease.

Grigg A. Grigg A. Intern Med J. 2007 Mar;37(3):190-2. doi: 10.1111/j.1445-5994.2006.01290.x. Intern Med J. 2007. PMID: 17316339

6

Cladribine followed by autologous stem-cell transplantation in progressive multiple sclerosis.

Grigg A, Tubridy NJ, Szer J, Mitchell P, Butzkueven H, Shuttleworth P, Kilpatrick T. Grigg A, et al. Intern Med J. 2004 Jan-Feb;34(1-2):66-9. doi: 10.1111/j.1444-0903.2004.00516.x. Intern Med J. 2004. PMID: 14748917

7

High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma. Australian and New Zealand Lymphoma Study Group.

Morton J, Taylor K, Bunce I, Eliadis P, Rentoul A, Moore D, Kelly C, Wright S, Bashford J, Rodwell R, Rooney K, Mulligan S, Firkin F, Dodds A, Parkin J, Lowenthal R, Kimber R, Frost T, Grigg A, Goldstein D, Stone J, Lee N. Morton J, et al. Among authors: grigg a. Br J Haematol. 1996 Oct;95(1):110-5. doi: 10.1046/j.1365-2141.1996.d01-1868.x. Br J Haematol. 1996. PMID: 8857946

8

Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.

Harrison CN, Campbell PJ, Buck G, Wheatley K, East CL, Bareford D, Wilkins BS, van der Walt JD, Reilly JT, Grigg AP, Revell P, Woodcock BE, Green AR; United Kingdom Medical Research Council Primary Thrombocythemia 1 Study. Harrison CN, et al. N Engl J Med. 2005 Jul 7;353(1):33-45. doi: 10.1056/NEJMoa043800. N Engl J Med. 2005. PMID: 16000354 Free article. Clinical Trial.

9

Successful donor leukocyte infusion for chronic myeloid leukemia relapsing in accelerated phase after T cell-replete unrelated marrow transplantation.

Grigg A, Szer J. Grigg A, et al. Bone Marrow Transplant. 1996 Sep;18(3):647-8. Bone Marrow Transplant. 1996. PMID: 8879633

10

G-CSF stimulated donor granulocyte collections for prophylaxis and therapy of neutropenic sepsis.

Grigg A, Vecchi L, Bardy P, Szer J. Grigg A, et al. Aust N Z J Med. 1996 Dec;26(6):813-8. doi: 10.1111/j.1445-5994.1996.tb00630.x. Aust N Z J Med. 1996. PMID: 9028513

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

400 results

Search Page